Indoco Remedies Ltd gets 7 observations from USFDA for Plant 2 and 3 at Goa

The United States Food and Drug Administration (USFDA) had inspected Company's manufacturing facilities at Plant II (Sterile) and Plant III located at Goa ("Facility") from July 16, 2024 to July 26, 2024. On conclusion of the inspection, the Company received 7 (seven) observations in Form 483.

We are addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe.

Shares of Indoco Remedies Limited was last trading in BSE at Rs. 323.55 as compared to the previous close of Rs. 324.10. The total number of shares traded during the day was 2076 in over 193 trades.

The stock hit an intraday high of Rs. 326.35 and intraday low of 320.40. The net turnover during the day was Rs. 670568.00.

Source : Equity Bulls

Keywords

IndocoRemedies INE873D01024 USFDA Inspection Plant2 Plant3 Sterile Goa Form483 7Observations